Enhancement of the T140-based pharmacophores leads to the development of more potent and bio-stable CXCR4 antagonists.
Tamamura H, Hiramatsu K, Mizumoto M, Ueda S, Kusano S, Terakubo S, Akamatsu M, Yamamoto N, Trent JO, Wang Z, Peiper SC, Nakashima H, Otaka A, Fujii N.
Tamamura H, et al. Among authors: nakashima h.
Org Biomol Chem. 2003 Nov 7;1(21):3663-9. doi: 10.1039/b306613b.
Org Biomol Chem. 2003.
PMID: 14649897